Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gender-specific effects of NAT2 and GSTM1 in bladder cancer.

Clinical genetics - 1 Apr 2000

Schnakenberg E, Lustig M, Breuer R, Werdin R, Hübotter R, Dreikorn K, Schloot W

Abstract excerpt

One approach for risk assessment of cancer is the evaluation of polymorphic enzymes involved in cancer using molecular tools. Phase II enzymes are involved in the detoxification of several drugs, environmental substances and carcinogenic compounds. Here, we analyzed enzymes for their putative relevance in urinary bladder cancer. The hereditable enzyme polymorphism of arylamine N-acetyltransferase 2 (NAT2) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Aged, 80 and over
Share to Arylamine N-Acetyltransferase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Glutathione Transferase

Share to Neoplasm Proteins

Share to Sex Factors

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 10845567
DOI: 10.1034/j.1399-0004.2000.570405.x

Genes

NAT2
GSTM1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gender-specific effects of NAT2 and GSTM1 in bladder cancer.PMID 10845567Read ↗

Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolizing enzymes.Semantic proximity Read ↗

NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.Semantic proximity Read ↗

Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.Semantic proximity Read ↗

N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.Semantic proximity Read ↗

Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.Semantic proximity Read ↗

NAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.Semantic proximity Read ↗

Polymorphic NATs and cancer predisposition.Semantic proximity Read ↗

Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.Semantic proximity Read ↗

Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.Semantic proximity Read ↗

Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.Semantic proximity Read ↗

Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.